Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Treatment adherence is improving: persistence improved from ~40% for those starting treatment in 2023 to 63% for those beginning in early 2024 (one-year continuation)
Perkovic V, Tuttle KR, Rossing P, et al
Addressing polypharmacy and comorbidities If you take several medications, have them all reviewed before starting GLP-1 therapy
Under APAP overdose conditions, a GSH severe depletion together with a significant increase of NAPQI occurs, leading to mitochondrial dysfunction, ATP depletion, oxidative stress, DNA damage and, finally, cell death
This work highlights why accurate analytical methods and biological understanding are essential before drawing conclusions about microplastics in human tissues
